Utilizing Thymosin Beta 4 Tβ4 to develop drug candidates in three principal areas dermal, ophthalmic, and cardiovascular wound healing. - RegeneRx

Pipeline Clinical Trials. SNNLive interview with J.J. Finkelstein, President and CEO of RegeneRx Biopharmaceuticals, Inc. at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY. Watch the video interview. Shareholder letter - Tuesday February 17, 2015. August 12, 2015. New Publication Elaborates on TB4s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. August 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. July 22, 2015.

OVERVIEW

The web site regenerx.com presently has an average traffic ranking of zero (the smaller the more users). We have crawled zero pages inside the web site regenerx.com and found six websites linking to regenerx.com. There are two contacts and locations for regenerx.com to help you communicate with them. There are one public communication sites enjoyed by regenerx.com. The web site regenerx.com has been online for one thousand three hundred and fifty-three weeks, ten days, three hours, and four minutes.
Links to this site
6
Contacts
2
Addresses
2
Social Links
1
Online Since
Aug 1999

REGENERX.COM TRAFFIC

The web site regenerx.com is seeing diverging quantities of traffic until the end of the year.
Traffic for regenerx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for regenerx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for regenerx.com

Date Range

All time
This Year
Last Year
Last Month

REGENERX.COM HISTORY

The web site regenerx.com was first submitted to the registrar on August 06, 1999. It was updated on the date of June 07, 2014. This web site will go back on the market on August 06, 2019. It is currently one thousand three hundred and fifty-three weeks, ten days, three hours, and four minutes young.
REGISTERED
August
1999
UPDATED
June
2014
EXPIRED
August
2019

AGE

25
YEARS
11
MONTHS
9
DAYS

LINKS TO REGENERX.COM

drug development and delivery home Drug Development Delivery

Featured Articles From The Current Issue. Sign Up for a Free Subscription. TASTE-MASKING - Pharmaceutical Taste-Masking Technologies.

Heart Diseases

Thursday, July 5, 2012. June 21, 2012 - Breakthrough Technology Advances Remote Monitoring Capabilities of the HeartAssist 5 System to Wirelessly Report Data when Patients are on the Move. 8211; MicroMed Cardiovascular Inc.

RegeneRx Investors - Overview

To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. RegeneRx Provides Update on Clinical Trials in U.

WHAT DOES REGENERX.COM LOOK LIKE?

Desktop Screenshot of regenerx.com Mobile Screenshot of regenerx.com Tablet Screenshot of regenerx.com

CONTACTS

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

REGENERX.COM SERVER

Our crawlers found that a single page on regenerx.com took two hundred and fifty-two milliseconds to download. Our web crawlers could not observe a SSL certificate, so I consider regenerx.com not secure.
Load time
0.252 sec
SSL
NOT SECURE
IP
173.203.62.111

NAME SERVERS

ns81.worldnic.com
ns82.worldnic.com

SERVER SOFTWARE AND ENCODING

We found that regenerx.com is using the Apache operating system.

SITE TITLE

Utilizing Thymosin Beta 4 Tβ4 to develop drug candidates in three principal areas dermal, ophthalmic, and cardiovascular wound healing. - RegeneRx

DESCRIPTION

Pipeline Clinical Trials. SNNLive interview with J.J. Finkelstein, President and CEO of RegeneRx Biopharmaceuticals, Inc. at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY. Watch the video interview. Shareholder letter - Tuesday February 17, 2015. August 12, 2015. New Publication Elaborates on TB4s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. August 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. July 22, 2015.

PARSED CONTENT

The web site has the following on the homepage, "Finkelstein, President and CEO of RegeneRx Biopharmaceuticals, Inc." I saw that the web site also said " at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY." They also said " Shareholder letter - Tuesday February 17, 2015. New Publication Elaborates on TB4s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. RegeneRx Provides Update on Clinical Trials in U."

SEE SIMILAR BUSINESSES

NetBeat Webhosting - www.netbeat.de

Wir wuenschen Ihnen viel Spaß mit NetBeat Webhosting.

Home Regenerys

Regenerys is a regenerative medicine company working with adipose tissue for breast reconstruction and plastic surgery, and in skin regeneration technology. We are HTA and MHRA licenced and are built on solid pillars of quality, regulatory compliance and experienced staff. The leadership team is advised by pre-eminent clinicians. Welcome to the new site! June 15, 2015.

Accessori casa Accessori ufficio Accessori moda

Visita il nostro E-shop e. Dalle tute dei piloti ad accessori moda. Pezzi unici dal design estremo. In un ambiente di lavoro. Le collezioni sono create dai designer. Più noti a livello internazionale, tra i quali Matali. Crasset, Marco Ferreri, Giulio Iacchetti, Setsu e Shinobu Ito,.

ReGenesis TV

In Search of ReGenesis Fan Fiction. Hello there, thought Id try to revive this comm a little bit. And I fell in love with it pretty much right away. It took me a mere week to plow my way through all four seasons. What a wild ride! And now I wish there was more of it.